Deutsche Bank Ag\ Akoya Biosciences, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Akoya Biosciences, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 10,868 shares of AKYA stock, worth $22,931. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,868

Previous 20,947 48.12%

Holding current value

$22,931

Previous $49,000 40.82%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$1.96 - $2.94 $19,754 - $29,632	-10,079 Reduced 48.12%	10,868 $29,000
Q2 2024 Aug 14, 2024	SELL	$1.94 - $4.56 $1,583 - $3,720	-816 Reduced 3.75%	20,947 $49,000
Q4 2023 Feb 14, 2024	BUY	$3.13 - $5.13 $65,470 - $107,304	20,917 Added 2472.46%	21,763 $106,000
Q3 2023 Nov 09, 2023	SELL	$4.24 - $7.44 $30,447 - $53,426	-7,181 Reduced 89.46%	846 $3,000
Q2 2023 Aug 14, 2023	SELL	$5.28 - $8.35 $12,714 - $20,106	-2,408 Reduced 23.08%	8,027 $59,000
Q1 2023 May 15, 2023	BUY	$7.6 - $12.68 $20,254 - $33,792	2,665 Added 34.3%	10,435 $85,000
Q4 2022 Feb 13, 2023	BUY	$8.6 - $14.1 $894 - $1,466	104 Added 1.36%	7,770 $74,000
Q3 2022 Nov 14, 2022	SELL	$10.63 - $15.76 $2.79 Million - $4.13 Million	-262,344 Reduced 97.16%	7,666 $90,000
Q2 2022 Aug 11, 2022	BUY	$8.38 - $12.85 $2.19 Million - $3.37 Million	261,897 Added 3228.12%	270,010 $3.47 Million
Q1 2022 May 13, 2022	SELL	$9.84 - $14.97 $413 - $628	-42 Reduced 0.52%	8,113 $89,000
Q4 2021 Feb 11, 2022	BUY	$11.37 - $15.31 $42,091 - $56,677	3,702 Added 83.13%	8,155 $125,000
Q3 2021 Nov 04, 2021	SELL	$13.04 - $21.0 $1,056 - $1,701	-81 Reduced 1.79%	4,453 $62,000
Q2 2021 Aug 11, 2021	BUY	$17.89 - $26.05 $81,113 - $118,110	4,534 New	4,534 $88,000

Others Institutions Holding AKYA

# of Institutions

Shares Held

11.9M

Call Options Held

24.1K

Put Options Held

View Full List

About Akoya Biosciences, Inc.

Ticker AKYA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 37,892,300
Market Cap $80M
Description
Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope...

More about AKYA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account